Compare LEG & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LEG | PRGO |
|---|---|---|
| Founded | 1883 | 1887 |
| Country | United States | Ireland |
| Employees | 15900 | N/A |
| Industry | Home Furnishings | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 2018 | 2013 |
| Metric | LEG | PRGO |
|---|---|---|
| Price | $10.80 | $11.37 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 3 |
| Target Price | $10.50 | ★ $19.33 |
| AVG Volume (30 Days) | ★ 3.7M | 2.8M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | 1.80% | ★ 10.08% |
| EPS Growth | ★ 145.31 | N/A |
| EPS | ★ 1.69 | N/A |
| Revenue | ★ $5,203,900,000.00 | $800,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.73 | $1.02 |
| P/E Ratio | $6.54 | ★ N/A |
| Revenue Growth | ★ 1.37 | N/A |
| 52 Week Low | $7.86 | $9.23 |
| 52 Week High | $13.00 | $28.44 |
| Indicator | LEG | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 48.21 | 50.92 |
| Support Level | $9.28 | $10.40 |
| Resistance Level | $11.94 | $12.13 |
| Average True Range (ATR) | 0.48 | 0.42 |
| MACD | -0.00 | 0.04 |
| Stochastic Oscillator | 40.25 | 54.62 |
Leggett & Platt Inc designs and produces engineered components and products found in homes and automobiles. It operates its business through three segments namely Bedding Products, Specialized Products, and Furniture, Flooring, and Textile Products. It generates the maximum of its revenue from Bedding Products. Serving a broad suite of customers around the world, Leggett & Platt's products include bedding components, automotive seat support, and lumbar systems, specialty bedding foam and private label finished mattresses, components for home furniture, and work furniture, flooring underlayment, adjustable beds, and various other products.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.